Documents & Downloads
You may order paper copies by contacting ProShares Client Services at 866-PRO-5125 (866-776-5125)
Performance
30 Day Daily Return
Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.
Total Return
Fund | 1m | 3m | 6m | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception | Inception Date |
---|---|---|---|---|---|---|---|---|---|---|
BIS Market Price | 6.12% | 9.71% | -18.47% | -9.14% | -35.58% | -3.66% | -24.59% | -21.83% | -32.10% | 04/07/2010 |
BIS NAV | 5.74% | 9.52% | -18.59% | -9.30% | -35.60% | -3.69% | -24.61% | -21.85% | -32.12% | 04/07/2010 |
Fund | 1m | 3m | 6m | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception | Inception Date |
---|---|---|---|---|---|---|---|---|---|---|
BIS Market Price | 4.88% | -8.79% | -12.77% | -14.38% | -30.36% | -4.51% | -27.73% | -23.72% | -32.54% | 04/07/2010 |
BIS NAV | 5.14% | -8.46% | -12.57% | -14.23% | -30.23% | -4.55% | -27.70% | -23.73% | -32.53% | 04/07/2010 |
The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.
About the Fund
Snapshot
- Ticker BIS
- Intraday Ticker BIS.IV
- CUSIP 74347G838
- Inception Date 4/7/10
- Gross Expense Ratio 2.42%
- Net Expense Ratio 0.95%
- NAV Calculation Time 4:00 p.m. ET
- Options Available Yes
Price
as of 11/29/2024- NAV $15.88
- NAV Change $+0.04
- Market Price $15.83
- Market Price Change $+0.02
- Trading Volume (M) 7,255
- 30-Day Median Bid Ask Spread 0.26%
- View Premium / Discount
Snapshot
- Ticker BIS
- Intraday Ticker BIS.IV
- CUSIP 74347G838
- Inception Date 4/7/10
- Expense Ratio 0.95%
- Gross Expense Ratio 2.42%
- NAV Calculation Time 4:00 p.m. ET
- Options Available Yes
Price
as of 11/29/2024- NAV $15.88
- NAV Change $+0.04
- Market Price $15.83
- Market Price Change $+0.02
- Trading Volume (M) 7,255
- 30-Day Median Bid Ask Spread 0.26%
- View Premium / Discount
Expenses with Contractual Waiver through September 30, 2025. Without the fee waiver performance would likely be lower.
Exposures
Index as of 9/30/2024
Holdings
as of 11/29/2024
Exposure Weight | Ticker | Description | Exposure Value (Notional + GL) |
Market Value | Shares/Contracts | SEDOL Number |
---|---|---|---|---|---|---|
-- | -- | TREASURY BILL | -- | $1,481,929.41 | 1,500,000 | BNDXZ56 |
-- | -- | NET OTHER ASSETS (LIABILITIES) | -- | $2,029,533.58 | 2,029,534 | -- |
-7.80% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA | -274,044 | -- | -59 | -- |
-12.83% | -- | NASDAQ BIO INDEX SWAP BNP PARIBAS | -450,547 | -- | -97 | -- |
-15.21% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP MORGAN STANLEY & CO. INTERNATIONAL PLC | -534,153 | -- | -115 | -- |
-20.77% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA | -729,235 | -- | -157 | -- |
-66.67% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG | -2,340,984 | -- | -504 | -- |
-76.46% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE | -2,684,700 | -- | -578 | -- |
Index
as of 9/30/2024
- Total Number of Companies214
- Price/Earnings Ratio--
- Price/Book Ratio4.157
- Dividend Yield ( % )0.88
- Avg. Index Market Capitalization$7.59 billion
About the Index
The Nasdaq Biotechnology Index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies.
Distributions
For
- 2024
- 2023
- 2020
- 2019
- 2018
Ex-Dividend Date | Record Date | Payable Date | Dividend | Long-Term Capital Gain | Short-Term Capital Gain | Return of Capital |
---|